Inventor · disambiguated record
Wei Qiu
Also filed as: QIU WEI · QIU WEI-ZHEN
8 granted patents·2 pending applications·48 citations·filing 2005–2024
84Inventor score
Top patents by PatentIndex Score
10 records- 0194US7582803B2Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disordersAMGEN INC·Filed 2006·Granted Sep 1, 2009·17 cites·19 claims
- 0291US11655212B2Using adiponectin receptor agonists to treat inflammation and bone diseases in diabetesTUFTS COLLEGE·Filed 2021·Granted May 23, 2023·2 cites·20 claims
- 0390US12098131B2Using adiponectin receptor agonists to treat inflammation and bone diseases in diabetesTUFTS COLLEGE·Filed 2023·Granted Sep 24, 2024·2 cites·20 claims
- 0489US7816367B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Oct 19, 2010·15 cites·25 claims
- 0585US7649110B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Jan 19, 2010·8 cites·37 claims
- 0683US10508113B2Inhibitors of tyrosine kinase 2 mediated signalingABBVIE INC·Filed 2019·Granted Dec 17, 2019·3 cites·30 claims
- 0779US12391646B2Using adiponectin receptor agonists to treat inflammation and bone diseases in diabetesTUFTS COLLEGE·Filed 2024·Granted Aug 19, 2025·0 cites·20 claims
- 0874US11302647B2Semiconductor device package including conductive layers as shielding and method of manufacturing the sameADVANCED SEMICONDUCTOR ENG·Filed 2020·Granted Apr 12, 2022·1 cites·18 claims
- 0964US2009275598A1Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disordersAMGEN INC·Filed 2009·Application pending·0 cites
- 1057US2020255423A1Inhibitors of tyrosine kinase 2 mediated signalingABBVIE INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wei Qiu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →